899 Cumbrians Prescribed Medical Cannabis
A total of 899 people in Cumbria have been prescribed medical cannabis through private provider Releaf, according to new figures.
The data highlights growing demand for cannabis-based treatments, which are typically prescribed for conditions such as chronic pain, anxiety and neurological disorders.
Breakdown by Area
The figures show how prescriptions are spread across different parts of Cumbria, with some areas seeing higher numbers than others.
The largest number of patients were recorded in:
- Carlisle (292), the highest share of prescriptions
- Barrow-in-Furness (161), which also saw a significant number of patients
Smaller numbers were recorded in:
- Allerdale
- Copeland
- more rural parts of the county
This distribution broadly reflects population size, with more urban areas showing higher totals.
Growth in Private Prescriptions
Medical cannabis can be prescribed legally in the UK, but access through the NHS remains limited. As a result, most patients obtain prescriptions through private clinics such as Releaf.
These prescriptions are typically used for conditions where other treatments have not been effective.
What the Figures Show
The total of 899 patients suggests a steady increase in the use of medical cannabis across Cumbria.
It also highlights:
- growing awareness of alternative treatments
- increased use of private healthcare options
- continued limits on NHS access
Ongoing Debate Around Use
While some patients report positive results, medical cannabis remains a topic of debate.
Supporters say it can improve quality of life for people with long-term conditions, while others point to:
- limited clinical evidence in some areas
- high private treatment costs
- variation in prescribing practices
Looking Ahead
The figures provide a snapshot of how medical cannabis is being used across Cumbria.
As awareness grows and access potentially expands, the number of patients using these treatments could continue to rise, particularly if NHS availability changes in the future.